Por qué es importante el diagnóstico precoz del CPRCM. Herramientas para el abordaje temprano - page 8

Enzalutamida

160 mg al día

Placebo diario

1:1

n = 1680 mCPRC

asintomático o levemente

sintomático

Progresión tras DA

Beer et al. NEJM 2014;371:424-33

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1,2,3,4,5,6,7 9,10,11,12,13,14,15,16,17,18,...32